OS in TP53-mutated myeloid disease. (A) OS of the entire cohort based on diagnosis and blast percentage. (B) OS for cases of MDS with <10% blasts classified as MDS-TP53 by both classifications vs cases of MDS with <10% blasts classified as MDS-TP53 by the ICC only (P=NS). (C-D) OS in patients with AML-TP53 compared to patients with AML-MR with wild-type TP53, both overall (C) and censored at the time of stem cell transplant (D).